KMT2A and cancer: Focusing specifically on cancer, P127-MLL@Gins, an oral nanoparticle composed of magnetic mesoporous silica loaded with 6-gingerol, coated with Pluronic F127 and mulberry leaf-derived lipids, has shown to promote intestinal release, and selectively target CRC tumor cells [58].